Despite its high incidence and devastating outcomes, acute respiratory distress syndrome
(ARDS) has no specific treatment, with effective therapy currently limited to minimizing …

Introduction: Pharmacotherapy for the acute respiratory distress syndrome (ARDS) has been
tested in preclinical and clinical studies. However, to date, no pharmacological interventions …

Overall, there is no proven pharmacological therapy in ARDS, but some pharmacological
interventions were associated with beneficial effects in certain subgroups of patients …

Introduction: The acute respiratory distress syndrome (ARDS) is a common and catastrophic
condition, with a high mortality rate and economic burden on society. Despite 50 years of …

The acute respiratory distress syndrome (ARDS) remains a common and highly morbid
condition despite advances in the understanding and management of this complex critical …

Over 50 years have passed since the acute respiratory distress syndrome (ARDS) was first
described. 1 Despite the passage of more than one-half of a century, almost all of ARDS …

Introduction: Acute respiratory distress syndromes (ARDS) are devastating disorders of
overwhelming pulmonary inflammation and hypoxemia, resulting in high morbidity and …

Pharmacological treatments for acute respiratory distress sy... : Current Opinion in Critical Care
Pharmacological treatments for acute respiratory distress syndrome : Current Opinion in …

The acute respiratory distress syndrome (ARDS) is a severe form of acute hypoxemic
respiratory failure caused by an insult to the alveolar-capillary membrane, resulting in a …

Acute respiratory distress syndrome represents a complex syndrome with considerable
morbidity and mortality, for which there exist no targeted treatment strategies. However …